Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
Status:
Completed
Trial end date:
2016-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- to assess clinical efficacy of Subetta in the combined treatment of type I diabetes
mellitus;
- to assess safety of Subetta in the combined treatment of type I diabetes mellitus.